Protein-functionalized and intrinsically radiolabeled [188Re]ReOx nanoparticles: advancing cancer therapy through concurrent radio-photothermal effects
Open Access
- 25 January 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 52 (7) , 2628-2644
Abstract
Purpose Enhancing therapeutic effectiveness is crucial for translating anticancer nanomedicines from laboratory to clinical settings. In this study, we have developed radioactive rhenium oxide nanoparticles encapsulated in human serum albumin ([188Re]ReOx-HSA NPs) for concurrent radiotherapy (RT) and photothermal therapy (PTT), aiming to optimize treatment outcomes. Methods [188Re]ReOx-HSA NPs were synthesized by a controlled reduction of 188ReO4− in HSA medium and extensively characterized. The anticancer effect of [188Re]ReOx-HSA NPs was demonstrated in vitro in murine melanoma (B16F10) cell line. In vivo SPECT/CT imaging, autoradiography and biodistribution studies were performed after intratumoral injection of [188Re]ReOx-HSA NPs in melanoma tumor-bearing C57BL/6 mice. The potential of [188Re]ReOx-HSA NPs for combined RT and PTT treatment was also demonstrated in the aforesaid mice model. Results [188Re]ReOx-HSA NPs (size 4–6 nm) were synthesized with high colloidal and radiochemical stability. Upon laser (808 nm) exposure on B16F10 cells incubated with [188Re]ReOx-HSA NPs, only < 20% of cells were alive demonstrating high therapeutic efficacy under in vitro settings. Uniform dose distribution and retention of the radiolabeled NPs in the tumor volume were observed via SPECT/CT imaging and autoradiography studies. Tumor growth in mice model was significantly arrested with ~ 1.85 MBq dose of [188Re]ReOx-HSA NPs and simultaneous laser irradiation, demonstrating synergistic benefit of RT and PTT. Conclusions These results demonstrate that intrinsically radiolabeled [188Re]ReOx-HSA NPs having unique features such as high photothermal effects and favorable nuclear decay characteristics for combined RT/PTT, hold great promise for clinical translation. Graphical AbstractKeywords
Funding Information
- Bhabha Atomic Research Centre
This publication has 64 references indexed in Scilit:
- Laser‐Synthesized Germanium Nanoparticles as Biodegradable Material for Near‐Infrared Photoacoustic Imaging and Cancer PhototherapyAdvanced Science, 2024
- Brachytherapy at the nanoscale with protein functionalized and intrinsically radiolabeled [169Yb]Yb2O3 nanoseedsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Evaluating the therapeutic efficacy of radiolabeled BSA@CuS nanoparticle‐induced radio‐photothermal therapy against anaplastic thyroid cancerIUBMB Life, 2022
- Mechanochemically synthesized mesoporous alumina: a smart new-generation sorbent for preparation of chromatographic 188W/188Re generatorSN Applied Sciences, 2021
- Reactor produced [64Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinicAnnals of Nuclear Medicine, 2020
- Radiochemical separation of no-carrier-added 186Re from proton irradiated tungsten targetJournal of Radioanalytical and Nuclear Chemistry, 2020
- Radionuclide‐Activated Nanomaterials and Their Biomedical ApplicationsAngewandte Chemie International Edition, 2019
- High‐Performance 2D Rhenium Disulfide (ReS2) Transistors and Photodetectors by Oxygen Plasma TreatmentAdvanced Materials, 2016
- Raman spectroscopy of proteins: a reviewJournal of Raman Spectroscopy, 2013
- The temperature dependence of the Raman spectrum of ammonium perrhenateJournal of Raman Spectroscopy, 1978